SGX queries Biolidics on timing of disclosure that authorities had approved its Covid-19 test kits
Medical technology firm says it made disclosure after it was certain kits could be commercialised
Add BT as a preferred source
Singapore
BIOLIDICS Ltd believes that it only became material to disclose that the firm had received approval for its virus test kits from Singapore's Health Sciences Authority (HSA) after it was certain that the kits could be commercialised.
In an exchange filing on Thursday, the firm also said it only received approval for the product to be manufactured and marketed under its own brand some time later.
TRENDING NOW
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Father-and-son duo Raj Kumar and Kishin in exclusive due diligence to buy Scotts Square
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
The factors that make South-east Asia’s top conglomerates stand out
